As of Feb 27
| -0.02 / -0.83%|
The 3 analysts offering 12-month price forecasts for Synta Pharmaceuticals Corp have a median target of 9.00, with a high estimate of 20.00 and a low estimate of 1.00. The median estimate represents a +275.00% increase from the last price of 2.40.
The current consensus among 3 polled investment analysts is to Buy stock in Synta Pharmaceuticals Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.